SCHEMBL15580340

SCHEMBL15580340

CCC(=O)c1ccccc1NC(=O)OC(C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.52
IDO1 P14902 1/20 0.51
LMNA P02545 2/20 0.47
POLB P06746 2/20 0.47
ELANE P08246 1/20 0.46
PRTN3 P24158 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C19 P33261 1/20 0.45
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 2/20 0.44
HPGD P15428 1/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
GAA P10253 1/20 0.42
CNR2 P34972 1/20 0.42
BRD9 Q9H8M2 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28576096 0.85 KDM4E (0.50) RXFP1IDO1LMNASMN1; SMN2CYP1A2
SCHEMBL21251514 0.84 SMN1; SMN2 (0.47) RXFP1LMNAPOLBSMN1; SMN2ALDH1A1
SCHEMBL13209430 0.84 RXFP1 (0.49) RXFP1IDO1LMNAPOLBSMN1; SMN2
SCHEMBL15368377 0.83 RXFP1 (0.59) RXFP1IDO1LMNAPOLBELANE
SCHEMBL222446 0.83 RXFP1 (0.55) RXFP1LMNAPOLBSMN1; SMN2KDM4E
SCHEMBL29992092 0.83 RXFP1 (0.59) RXFP1IDO1LMNAPOLBELANE
SCHEMBL29663621 0.83 RXFP1 (0.55) RXFP1IDO1LMNAPOLBELANE
SCHEMBL29702265 0.83 RXFP1 (0.55) RXFP1LMNAPOLBSMN1; SMN2KDM4E
SCHEMBL28493853 0.82 KDM4E (0.60) LMNAELANEPRTN3SMN1; SMN2CYP1A2
SCHEMBL15725383 0.82 RXFP1 (0.47) RXFP1IDO1LMNAPOLBELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2398789-B1 SPIROPYRROLIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK SHARP & DOHME (US) 2014-03-19 EP disclosed
WO-2010094242-A1 SPIROPYRROLIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK SHARP & DOHME CORP. (US) 2010-08-26 WO disclosed
CN-1802361-A M-stage kinesin inhibitor KYOWA HAKKO KOGYO KK (JP) 2006-07-12 CN disclosed